Advertisement

Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab

Catherine Lai, Vishal Ranpura, Colin Wu, Matthew J. Olnes, Ankur R. Parikh, Aarthi Shenoy, Julie Thompson, Barbara Weinstein, Phillip Scheinberg, A. John Barrett, Ronan Desmond, Neal S. Young and Christopher S. Hourigan

Article Information

Citation 
vol. 3 no. 7 980-983
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted December 21, 2018
  • Accepted February 15, 2019
  • Published online April 1, 2019.


Contributors 
  • Catherine Lai, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
  • Vishal Ranpura, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
  • Colin Wu, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
  • Matthew J. Olnes, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
  • Ankur R. Parikh, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
  • Aarthi Shenoy, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
  • Julie Thompson, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
  • Barbara Weinstein, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
  • Phillip Scheinberg, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
  • A. John Barrett, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
  • Ronan Desmond, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
  • Neal S. Young, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
  • Christopher S. Hourigan, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output